News

Company News & Events

ORYZON to present at upcoming international conferences

11 November 2019

MADRID, SPAIN and CAMBRIDGE MA.

  • 25th Annual International Partnering Conference BIO-Europe-2019, Hamburg, Germany
  • Jefferies London Healthcare Conference, London, UK

Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical needs, announced today that Executive Directors of the company will present at several reputed international conferences in November.

 

Click here to see the full Press Release

 

Posted In: 
News
Investors

Share this story